Literature DB >> 15075047

Valsartan in acute myocardial infarction trial.

Ileana L Piña.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075047

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  9 in total

1.  Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young.

Authors:  R G Hart
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.

Authors:  Douglas L Mann; Anita Deswal
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

3.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Authors:  J N Cohn; G Tognoni
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

4.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Authors:  B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

5.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

6.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors:  John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

7.  The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.

Authors:  M A Pfeffer
Journal:  Herz       Date:  1993-12       Impact factor: 1.443

Review 8.  Prevention of stroke in patients with nonvalvular atrial fibrillation.

Authors:  R G Hart; D G Sherman; J D Easton; J A Cairns
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.

Authors:  Prashanthan Sanders; Joseph B Morton; Neil C Davidson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

  9 in total
  2 in total

1.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2021-05-22

Review 2.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.